Dr. Dennis Mumo Mbuve
Lead Pharmacist – Nairobi Hospital Cancer Centre
Vice Secretary – OPSOK
Quick Facts
- Experience: 6+ years in oncology pharmacy
- Specialization: Chemotherapy, Immunotherapy & Targeted Therapies
- Current Role: Lead Pharmacist, Nairobi Hospital Cancer Centre
- Focus: Multidisciplinary Oncology Care & Patient Safety
Advancing Precision Oncology Pharmacy
Dr. Mbuve's expertise in complex cancer therapies and commitment to patient safety are shaping modern oncology pharmacy practice at one of Kenya’s leading cancer centers.
Professional Overview
Dr. Dennis Mumo Mbuve is a dedicated oncology pharmacist with over six years of specialized experience in managing cancer pharmacotherapy. As Lead Pharmacist at the Nairobi Hospital Cancer Centre, he oversees the safe and effective delivery of chemotherapy, targeted therapies, and immunotherapies within a multidisciplinary care framework.
His work emphasizes precision medicine, medication safety, and patient-centered care, ensuring that each treatment plan is optimized for efficacy and tolerability. Dr. Mbuve plays a vital role in bridging clinical pharmacy with oncology teams to enhance treatment outcomes and reduce adverse events.
Clinical Expertise & Service Leadership
Complex Therapy Management
Leads the review and verification of high-risk chemotherapy regimens, ensuring protocol adherence and patient safety.
Immunotherapy & Targeted Agents
Specializes in the pharmacokinetics and monitoring of novel biologic therapies, including checkpoint inhibitors and kinase inhibitors.
Patient Safety & Risk Reduction
Implements safety protocols for hazardous drug handling, IV compounding, and error prevention in oncology pharmacy.
Supportive Care Optimization
Manages antiemetic, pain, and symptom control regimens to improve quality of life during cancer treatment.
Active Contributor to International Oncology Standards
Dr. Mbuve actively participates in global oncology pharmacy networks, promoting evidence-based practices and local adaptation of international treatment guidelines.
Professional Engagement & Guidelines Development
OPSOK Executive Committee
CurrentAs Vice Secretary, he supports organizational governance, strategic planning, and coordination of national oncology pharmacy initiatives.
ISOPP Member
OngoingEngages with the International Society of Oncology Pharmacy Practitioners to advance global standards in oncology pharmacy practice.
ESMO Involvement
CurrentFollows ESMO clinical practice guidelines and contributes to their contextualization for Kenyan healthcare settings.
Medication Safety Advocacy
2020–PresentChampioned internal pharmacy audits and staff training programs that reduced medication errors by 40% over two years.
Leadership in Oncology Pharmacy Practice
Dr. Mbuve is committed to strengthening the role of pharmacists in cancer care through:
- Interdisciplinary Collaboration: Facilitating daily tumor boards and treatment planning sessions with oncologists and nurses.
- Clinical Protocol Development: Contributing to institutional chemotherapy order sets and safety checklists.
- Staff Training & Mentorship: Leading onboarding and continuous education for pharmacy technicians and junior pharmacists.
- Patient Education: Designing clear, accessible materials to help patients understand their treatment regimens and side effect management.
- Research & Quality Improvement: Participating in audits and process evaluations to drive service excellence.
Vision for OPSOK & Oncology Pharmacy
As Vice Secretary of OPSOK, Dr. Mbuve envisions a future where:
National Standardization: Uniform oncology pharmacy practices are adopted across Kenyan hospitals, ensuring equitable, high-quality care.
Pharmacist Empowerment: Oncology pharmacists are formally integrated into multidisciplinary teams with defined roles and responsibilities.
Safety-First Culture: Robust systems are in place to prevent medication errors and ensure safe handling of hazardous drugs.
Continuing Professional Development: Regular training, certification, and knowledge-sharing platforms keep oncology pharmacists at the forefront of innovation.
“Pharmacists Are Essential in the Cancer Journey”
"From verifying complex regimens to counseling patients on side effects, our role goes beyond dispensing. We are guardians of safety, partners in care, and advocates for better outcomes."
